Fauci says COVID won’t be pandemic long, thanks to vaccines

https://www.theedgemarkets.com/article/fauci-says-covid-wont-be-pandemic-long-thanks-vaccines

Yes too careless. Must be lack of sleep. It’s okay I will average down if necessary.

@Noobie123 I accidentally sold it at 0.180 today. Actually I wanted to put stop loss order at 0.165 instead. I bought back at 0.175 swt.

Welcome. @Noobie123 whats your average buy price now ?

SATS able to transport Pfizer’s experimental Covid-19 vaccine at low temperatures — CEO

https://www.theedgemarkets.com/article/sats-able-transport-pfizers-experimental-covid19-vaccine-low-temperatures-%E2%80%94-ceo

SATS able to transport Pfizer’s experimental Covid-19 vaccine at low temperatures — CEO

https://www.theedgemarkets.com/article/sats-able-transport-pfizers-experimental-covid19-vaccine-low-temperatures-%E2%80%94-ceo

WHO says in talks with Russian institute on Sputnik V COVID-19 vaccine

https://www.thestar.com.my/news/world/2020/11/12/who-says-in-talks-with-russian-institute-on-sputnik-v-covid-19-vaccinea

WHO says in talks with Russian institute on Sputnik V COVID-19 vaccine

https://www.thestar.com.my/news/world/2020/11/12/who-says-in-talks-with-russian-institute-on-sputnik-v-covid-19-vaccinea

China's Sinopharm says data 'better than expected' from it's COVID vaccine trial

https://www.livemint.com/companies/news/china-s-sinopharm-says-data-better-than-expected-from-it-s-covid-vaccine-trial-11605100199684.html

China's Sinopharm says data 'better than expected' from it's COVID vaccine trial

https://www.livemint.com/companies/news/china-s-sinopharm-says-data-better-than-expected-from-it-s-covid-vaccine-trial-11605100199684.html

China's Sinopharm says data 'better than expected' from it's COVID vaccine trial

https://www.livemint.com/companies/news/china-s-sinopharm-says-data-better-than-expected-from-it-s-covid-vaccine-trial-11605100199684.html

aiyoo No need to be sour grapes lolol

This aiyoo real joker i tell you. Can be comedian.

@aiyoo Dont be sour grapes just because you didnt get to buy at 0.145 lolol

@aiyooo I think you are the shark instead lol Admit it

Patience is a virtue

Today most likely close at 0.170

@DrHash. Reasonable amount haha

Most likely closing 0.170

@aiyooo Pity you. Look back at your comment history for other stocks also so negative. Try to be more positive dear.

@aiyoo Your friend is the shark ah ? lololol

@aiyoo Pls stop dreaming. Wake up.

Today most likely close at 0.175

Morocco presses ahead with vaccine campaign preparations

In implementation of Royal guidelines to roll out coronavirus vaccine for all, head of the government Saad Eddine El Othmani said that preparations are underway and the safety and health of citizens is a priority.

“Our country’s choice for a vaccine is based on the criteria of safety and efficiency,” said El Othmani at the weekly cabinet meeting held Thursday.

THE TRIALS HAVE SHOWN THE VACCINE TO BE ADOPTED BY MOROCCO TO BE SAFE AND EFFICIENT, HE SAID, ADDING THAT MOROCCO WORKS IN CLOSE COOPERATION WITH THE WORLD HEALTH ORGANIZATION to that end.

Morocco had taken part in trials for the Chinese SINOPHARM vaccine and has ordered doses of the R-Pharm vaccine developed under a contract from the UK’s AstraZenica, which produced a vaccine in collaboration with Oxford University.

https://northafricapost.com/45150-morocco-presses-ahead-with-vaccine-campaign-preparations.html

Morocco presses ahead with vaccine campaign preparations

In implementation of Royal guidelines to roll out coronavirus vaccine for all, head of the government Saad Eddine El Othmani said that preparations are underway and the safety and health of citizens is a priority.

“Our country’s choice for a vaccine is based on the criteria of safety and efficiency,” said El Othmani at the weekly cabinet meeting held Thursday.

THE TRIALS HAVE SHOWN THE VACCINE TO BE ADOPTED BY MOROCCO TO BE SAFE AND EFFICIENT, HE SAID, ADDING THAT MOROCCO WORKS IN CLOSE COOPERATION WITH THE WORLD HEALTH ORGANIZATION to that end.

Morocco had taken part in trials for the Chinese SINOPHARM vaccine and has ordered doses of the R-Pharm vaccine developed under a contract from the UK’s AstraZenica, which produced a vaccine in collaboration with Oxford University.

https://northafricapost.com/45150-morocco-presses-ahead-with-vaccine-campaign-preparations.html

Morocco presses ahead with vaccine campaign preparations

In implementation of Royal guidelines to roll out coronavirus vaccine for all, head of the government Saad Eddine El Othmani said that preparations are underway and the safety and health of citizens is a priority.

“Our country’s choice for a vaccine is based on the criteria of safety and efficiency,” said El Othmani at the weekly cabinet meeting held Thursday.

THE TRIALS HAVE SHOWN THE VACCINE TO BE ADOPTED BY MOROCCO TO BE SAFE AND EFFICIENT, HE SAID, ADDING THAT MOROCCO WORKS IN CLOSE COOPERATION WITH THE WORLD HEALTH ORGANIZATION to that end.

Morocco had taken part in trials for the Chinese SINOPHARM vaccine and has ordered doses of the R-Pharm vaccine developed under a contract from the UK’s AstraZenica, which produced a vaccine in collaboration with Oxford University.

https://northafricapost.com/45150-morocco-presses-ahead-with-vaccine-campaign-preparations.html

Morocco presses ahead with vaccine campaign preparations

In implementation of Royal guidelines to roll out coronavirus vaccine for all, head of the government Saad Eddine El Othmani said that preparations are underway and the safety and health of citizens is a priority.

“Our country’s choice for a vaccine is based on the criteria of safety and efficiency,” said El Othmani at the weekly cabinet meeting held Thursday.

THE TRIALS HAVE SHOWN THE VACCINE TO BE ADOPTED BY MOROCCO TO BE SAFE AND EFFICIENT, HE SAID, ADDING THAT MOROCCO WORKS IN CLOSE COOPERATION WITH THE WORLD HEALTH ORGANIZATION to that end.

Morocco had taken part in trials for the Chinese SINOPHARM vaccine and has ordered doses of the R-Pharm vaccine developed under a contract from the UK’s AstraZenica, which produced a vaccine in collaboration with Oxford University.

https://northafricapost.com/45150-morocco-presses-ahead-with-vaccine-campaign-preparations.html

Morocco presses ahead with vaccine campaign preparations

In implementation of Royal guidelines to roll out coronavirus vaccine for all, head of the government Saad Eddine El Othmani said that preparations are underway and the safety and health of citizens is a priority.

“Our country’s choice for a vaccine is based on the criteria of safety and efficiency,” said El Othmani at the weekly cabinet meeting held Thursday.

THE TRIALS HAVE SHOWN THE VACCINE TO BE ADOPTED BY MOROCCO TO BE SAFE AND EFFICIENT, HE SAID, ADDING THAT MOROCCO WORKS IN CLOSE COOPERATION WITH THE WORLD HEALTH ORGANIZATION to that end.

Morocco had taken part in trials for the Chinese SINOPHARM vaccine and has ordered doses of the R-Pharm vaccine developed under a contract from the UK’s AstraZenica, which produced a vaccine in collaboration with Oxford University.

https://northafricapost.com/45150-morocco-presses-ahead-with-vaccine-campaign-preparations.html

Morocco presses ahead with vaccine campaign preparations

In implementation of Royal guidelines to roll out coronavirus vaccine for all, head of the government Saad Eddine El Othmani said that preparations are underway and the safety and health of citizens is a priority.

“Our country’s choice for a vaccine is based on the criteria of safety and efficiency,” said El Othmani at the weekly cabinet meeting held Thursday.

THE TRIALS HAVE SHOWN THE VACCINE TO BE ADOPTED BY MOROCCO TO BE SAFE AND EFFICIENT, HE SAID, ADDING THAT MOROCCO WORKS IN CLOSE COOPERATION WITH THE WORLD HEALTH ORGANIZATION to that end.

Morocco had taken part in trials for the Chinese Sinopharm vaccine and has ordered doses of the R-Pharm vaccine developed under a contract from the UK’s AstraZenica, which produced a vaccine in collaboration with Oxford University.

https://northafricapost.com/45150-morocco-presses-ahead-with-vaccine-campaign-preparations.html

@Newbietrader42069 What price did you get?

Whoever dreaming to buy in at 0.145. Please wake up from your dream.

@jeffrey8633 Please dont dream. Told you already hop on the boat before it is too late.

Vaccine news everywhere. Sure up

Dont dream you can get 0.145. Hop on the boat now before it is too late.

@Newbietrader42069 Dont miss the boat. Vaccine theme is coming.

Vaccine theme is all coming. Even Moderna is on the way.

Moderna looks to first interim analysis in COVID-19 vaccine Phase 3 trial

https://www.biopharma-reporter.com/Article/2020/11/12/Moderna-looks-to-first-interim-analysis-in-COVID-19-vaccine-Phase-3-trial

-------------
Crucial Moderna Covid vaccine data is coming in days — here’s what to look out for

https://www.cnbc.com/2020/11/12/coronavirus-moderna-vaccine-data-is-coming-in-days-what-to-look-out-for.html

Maybe if lucky can close at 0.175

Today will close at 0.170

Moderna looks to first interim analysis in COVID-19 vaccine Phase 3 trial

https://www.biopharma-reporter.com/Article/2020/11/12/Moderna-looks-to-first-interim-analysis-in-COVID-19-vaccine-Phase-3-trial

-------------
Crucial Moderna Covid vaccine data is coming in days — here’s what to look out for

https://www.cnbc.com/2020/11/12/coronavirus-moderna-vaccine-data-is-coming-in-days-what-to-look-out-for.html

Moderna looks to first interim analysis in COVID-19 vaccine Phase 3 trial

https://www.biopharma-reporter.com/Article/2020/11/12/Moderna-looks-to-first-interim-analysis-in-COVID-19-vaccine-Phase-3-trial

-------------
Crucial Moderna Covid vaccine data is coming in days — here’s what to look out for

https://www.cnbc.com/2020/11/12/coronavirus-moderna-vaccine-data-is-coming-in-days-what-to-look-out-for.html

Moderna looks to first interim analysis in COVID-19 vaccine Phase 3 trial

https://www.biopharma-reporter.com/Article/2020/11/12/Moderna-looks-to-first-interim-analysis-in-COVID-19-vaccine-Phase-3-trial

-------------
Crucial Moderna Covid vaccine data is coming in days — here’s what to look out for

https://www.cnbc.com/2020/11/12/coronavirus-moderna-vaccine-data-is-coming-in-days-what-to-look-out-for.html

Moderna looks to first interim analysis in COVID-19 vaccine Phase 3 trial

https://www.biopharma-reporter.com/Article/2020/11/12/Moderna-looks-to-first-interim-analysis-in-COVID-19-vaccine-Phase-3-trial

-------------
Crucial Moderna Covid vaccine data is coming in days — here’s what to look out for

https://www.cnbc.com/2020/11/12/coronavirus-moderna-vaccine-data-is-coming-in-days-what-to-look-out-for.html

Moderna looks to first interim analysis in COVID-19 vaccine Phase 3 trial

https://www.biopharma-reporter.com/Article/2020/11/12/Moderna-looks-to-first-interim-analysis-in-COVID-19-vaccine-Phase-3-trial

-------------
Crucial Moderna Covid vaccine data is coming in days — here’s what to look out for

https://www.cnbc.com/2020/11/12/coronavirus-moderna-vaccine-data-is-coming-in-days-what-to-look-out-for.html

Moderna looks to first interim analysis in COVID-19 vaccine Phase 3 trial

https://www.biopharma-reporter.com/Article/2020/11/12/Moderna-looks-to-first-interim-analysis-in-COVID-19-vaccine-Phase-3-trial

-------------
Crucial Moderna Covid vaccine data is coming in days — here’s what to look out for

https://www.cnbc.com/2020/11/12/coronavirus-moderna-vaccine-data-is-coming-in-days-what-to-look-out-for.html

Moderna looks to first interim analysis in COVID-19 vaccine Phase 3 trial

https://www.biopharma-reporter.com/Article/2020/11/12/Moderna-looks-to-first-interim-analysis-in-COVID-19-vaccine-Phase-3-trial

-------------
Crucial Moderna Covid vaccine data is coming in days — here’s what to look out for

https://www.cnbc.com/2020/11/12/coronavirus-moderna-vaccine-data-is-coming-in-days-what-to-look-out-for.html

Moderna looks to first interim analysis in COVID-19 vaccine Phase 3 trial

https://www.biopharma-reporter.com/Article/2020/11/12/Moderna-looks-to-first-interim-analysis-in-COVID-19-vaccine-Phase-3-trial

-------------
Crucial Moderna Covid vaccine data is coming in days — here’s what to look out for

https://www.cnbc.com/2020/11/12/coronavirus-moderna-vaccine-data-is-coming-in-days-what-to-look-out-for.html

Moderna looks to first interim analysis in COVID-19 vaccine Phase 3 trial

https://www.biopharma-reporter.com/Article/2020/11/12/Moderna-looks-to-first-interim-analysis-in-COVID-19-vaccine-Phase-3-trial

-------------
Crucial Moderna Covid vaccine data is coming in days — here’s what to look out for

https://www.cnbc.com/2020/11/12/coronavirus-moderna-vaccine-data-is-coming-in-days-what-to-look-out-for.html

Moderna looks to first interim analysis in COVID-19 vaccine Phase 3 trial

https://www.biopharma-reporter.com/Article/2020/11/12/Moderna-looks-to-first-interim-analysis-in-COVID-19-vaccine-Phase-3-trial

-------------
Crucial Moderna Covid vaccine data is coming in days — here’s what to look out for

https://www.cnbc.com/2020/11/12/coronavirus-moderna-vaccine-data-is-coming-in-days-what-to-look-out-for.html

Moderna looks to first interim analysis in COVID-19 vaccine Phase 3 trial

https://www.biopharma-reporter.com/Article/2020/11/12/Moderna-looks-to-first-interim-analysis-in-COVID-19-vaccine-Phase-3-trial

-------------
Crucial Moderna Covid vaccine data is coming in days — here’s what to look out for

https://www.cnbc.com/2020/11/12/coronavirus-moderna-vaccine-data-is-coming-in-days-what-to-look-out-for.html

Moderna looks to first interim analysis in COVID-19 vaccine Phase 3 trial

https://www.biopharma-reporter.com/Article/2020/11/12/Moderna-looks-to-first-interim-analysis-in-COVID-19-vaccine-Phase-3-trial

-------------
Crucial Moderna Covid vaccine data is coming in days — here’s what to look out for

https://www.cnbc.com/2020/11/12/coronavirus-moderna-vaccine-data-is-coming-in-days-what-to-look-out-for.html